Novel ALK immunohistochemistry assay (clone OTI1A4, Dako) is a sensitive, reliable marker for identifying ALK rearrangements in lung adenocarcinomas: A validation study
American Journal of Clinical Pathology · 2024
DOI: 10.1093/ajcp/aqad111 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2024. Verfasst von Ozgur Can Eren und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Koç University School of Medicine, Istanbul, Turkey. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ventana.
Abstract (Originalsprache)
Objectives
We present the first study validating the recent Dako ALK assay (clone OTI1A4, in vitro diagnostic) for detecting ALK rearrangements in lung adenocarcinoma.
Methods
Lung adenocarcinoma cases between 2011 and 2023 were retrospectively collected to create a cohort of 203 samples. Cases were stained with Dako ALK OTI1A4 and Ventana ALK D5F3 and reviewed by 3 pathologists independently. Correlation between assays, including their sensitivity and specificity, was evaluated.
Results
The cohort (n = 203) consisted of resections, core needle biopsies, and cell blocks. Agreement between Dako ALK OTI1A4 and Ventana ALK D5F3 assays was “almost perfect,” with κ = 0.89. The sensitivity and specificity of the Dako ALK OTI1A4 assay were 93.3% and 96%, respectively, in a subgroup of 55 molecularly confirmed cases (n = 30 with and n = 25 without ALK rearrangement).
Conclusions
Immunohistochemistry-based assays provide a valid and reasonably priced alternative, especially in settings where molecular confirmatory tests are neither offered nor accessible. Given high interassay and molecular concordance, we propose that the novel Dako OTI1A4 assay can be reliably used to identify cases with ALK rearrangement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Koç University School of Medicine, Istanbul, Turkey.
- Department of Immunology, Graduate School of Health Sciences, Koç University, Istanbul, Turkey.
- Koç University IsBank Research Center for Infectious Diseases, Istanbul, Turkey.
- Department of Pathology, Marmara University School of Medicine, Istanbul, Turkey.
- Department of Biostatistics, Koç University School of Medicine, Istanbul, Turkey.
- Research Center for Translational Medicine, Koç University, Istanbul, Turkey.
ORCID-Profile: Ibrahim Kulac
Förderung
- Ventana
Zitieren
APA
Eren, O. C., Mericoz, C. A., Bozkurtlar, E., Bulutay, P., Baygul, A., & Kulac, I. (2024). Novel ALK immunohistochemistry assay (clone OTI1A4, Dako) is a sensitive, reliable marker for identifying ALK rearrangements in lung adenocarcinomas: A validation study. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqad111
Vancouver
Eren OC, Mericoz CA, Bozkurtlar E, Bulutay P, Baygul A, Kulac I. Novel ALK immunohistochemistry assay (clone OTI1A4, Dako) is a sensitive, reliable marker for identifying ALK rearrangements in lung adenocarcinomas: A validation study. American Journal of Clinical Pathology. 2024. doi:10.1093/ajcp/aqad111
BibTeX
@article{Eren2024,
author = {Eren, Ozgur Can and Mericoz, Cisel Aydin and Bozkurtlar, Emine and Bulutay, Pinar and Baygul, Arzu and Kulac, Ibrahim},
title = {Novel ALK immunohistochemistry assay (clone OTI1A4, Dako) is a sensitive, reliable marker for identifying ALK rearrangements in lung adenocarcinomas: A validation study},
journal = {American Journal of Clinical Pathology},
year = {2024},
doi = {10.1093/ajcp/aqad111}
}
EUVIMED